Brief: Qualigen Therapeutics, Inc. Reports Q4 Financial Results
02/05/2023 22:37
May 2 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. REPORTS FOURTH QUARTER AND
YEAR-END
2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* QUALIGEN THERAPEUTICS INC FY LOSS PER SHARE $4.85
Source text for Eikon: ID:nGNX8SFcN4
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise